ONTOLOGY REPORT - ANNOTATIONS
Tuberculosis
|
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
Severity |
ISS |
20 |
4,250,613 |
4,253,540 |
RGD:6767307 |
RGD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
Susceptibility |
ISS |
10 |
70,380,498 |
70,383,276 |
RGD:4891408 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:7240710 |
OMIM |
| G |
Cd209a |
CD209a molecule |
|
|
ISS |
12 |
2,358,909 |
2,364,492 |
RGD:7240710 |
OMIM |
| G |
Cd209c |
CD209c molecule |
|
|
ISS |
12 |
2,236,285 |
2,244,559 |
RGD:5131181 |
RGD |
| G |
Cd209c |
CD209c molecule |
|
|
ISS |
12 |
2,236,285 |
2,244,559 |
RGD:5131186 |
RGD |
| G |
Cd86 |
CD86 molecule |
|
|
ISS |
11 |
66,215,233 |
66,238,882 |
RGD:4892329 |
RGD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
|
ISS |
8 |
112,541,034 |
112,545,982 |
RGD:7240710 |
OMIM |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
|
ISS |
14 |
17,284,085 |
17,288,996 |
RGD:5135308 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
ISS |
7 |
57,621,756 |
57,625,792 |
RGD:7240710 |
OMIM |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
|
ISS |
1 |
14,846,369 |
14,864,804 |
RGD:4144122 |
RGD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
|
ISS |
1 |
14,846,369 |
14,864,804 |
RGD:7240710 |
OMIM |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:4987456 |
RGD |
| G |
Il22 |
interleukin 22 |
|
|
ISS |
7 |
57,517,321 |
57,521,786 |
RGD:5147402 |
RGD |
| G |
Irgm |
immunity-related GTPase family, M |
|
|
ISS |
10 |
34,132,512 |
34,140,450 |
RGD:7240710 |
OMIM |
| G |
LOC24906 |
RoBo-1 |
|
|
IEA |
10 |
44,072,418 |
44,080,785 |
RGD:1331525 |
RGD |
| G |
Mc3r |
melanocortin 3 receptor |
|
|
ISS |
3 |
163,158,776 |
163,159,873 |
RGD:7240710 |
OMIM |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
|
ISS |
20 |
4,671,489 |
4,681,058 |
RGD:5147633 |
RGD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
|
ISS |
20 |
4,671,489 |
4,681,058 |
RGD:5147605 |
RGD |
| G |
Slc11a1 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
|
ISS |
9 |
73,714,692 |
73,725,523 |
RGD:5684931 |
RGD |
| G |
Slc11a1 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
|
ISS |
9 |
73,714,692 |
73,725,523 |
RGD:7240710 |
OMIM |
| G |
Sp110 |
SP110 nuclear body protein |
|
|
ISS |
9 |
84,258,232 |
84,279,462 |
RGD:7240710 |
OMIM |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
ISS |
|
|
|
RGD:1581371 |
RGD |
| G |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
|
|
ISS |
8 |
34,966,856 |
34,969,727 |
RGD:7240710 |
OMIM |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:7240710 |
OMIM |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144821 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143229 |
RGD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
|
ISS |
5 |
163,666,541 |
163,697,484 |
RGD:5131209 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
Susceptibility |
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:4889839 |
RGD |
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO
|
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:7240710 |
OMIM |
| G |
Cd209a |
CD209a molecule |
|
|
ISS |
12 |
2,358,909 |
2,364,492 |
RGD:7240710 |
OMIM |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
|
ISS |
8 |
112,541,034 |
112,545,982 |
RGD:7240710 |
OMIM |
| G |
Ifng |
interferon gamma |
|
|
ISS |
7 |
57,621,756 |
57,625,792 |
RGD:7240710 |
OMIM |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
|
ISS |
1 |
14,846,369 |
14,864,804 |
RGD:7240710 |
OMIM |
| G |
Irgm |
immunity-related GTPase family, M |
|
|
ISS |
10 |
34,132,512 |
34,140,450 |
RGD:7240710 |
OMIM |
| G |
Mc3r |
melanocortin 3 receptor |
|
|
ISS |
3 |
163,158,776 |
163,159,873 |
RGD:7240710 |
OMIM |
| G |
Slc11a1 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
|
ISS |
9 |
73,714,692 |
73,725,523 |
RGD:7240710 |
OMIM |
| G |
Sp110 |
SP110 nuclear body protein |
|
|
ISS |
9 |
84,258,232 |
84,279,462 |
RGD:7240710 |
OMIM |
| G |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
|
|
ISS |
8 |
34,966,856 |
34,969,727 |
RGD:7240710 |
OMIM |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:7240710 |
OMIM |
Tuberculosis, Meningeal
|
| G |
Il4r |
interleukin 4 receptor |
|
|
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:5128510 |
RGD |
Tuberculosis, Multidrug-Resistant
|
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
|
ISS |
20 |
4,730,559 |
4,736,201 |
RGD:5147828 |
RGD |
| G |
RT1-Db1 |
RT1 class II, locus Db1 |
|
|
ISS |
20 |
4,671,489 |
4,681,058 |
RGD:5147828 |
RGD |
Tuberculosis, Pleural
|
| G |
Ccl22 |
chemokine (C-C motif) ligand 22 |
|
|
ISS |
19 |
10,697,324 |
10,704,129 |
RGD:4891473 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:4145106 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:4145106 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143226 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143226 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5129700 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144193 |
RGD |
| G |
Tnc |
tenascin C |
|
|
ISS |
|
|
|
RGD:4889594 |
RGD |
Tuberculosis, Pulmonary
|
| G |
Ada |
adenosine deaminase |
|
|
ISS |
3 |
154,636,530 |
154,660,637 |
RGD:5128854 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:5686405 |
RGD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
Susceptibility |
ISS |
4 |
152,610,283 |
152,657,891 |
RGD:4890411 |
RGD |
| G |
C3 |
complement component 3 |
|
|
ISS |
|
|
|
RGD:5129500 |
RGD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
|
ISS |
10 |
70,380,498 |
70,383,276 |
RGD:4891409 |
RGD |
| G |
Ccl1 |
chemokine (C-C motif) ligand 1 |
|
Susceptibility |
ISS |
10 |
70,380,498 |
70,383,276 |
RGD:4891408 |
RGD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
|
ISS |
5 |
59,221,738 |
59,223,682 |
RGD:5130906 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
Susceptibility |
ISS |
10 |
70,256,263 |
70,258,061 |
RGD:4891439 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
Susceptibility |
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:4891879 |
RGD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
|
ISS |
10 |
71,605,791 |
71,610,330 |
RGD:4892112 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
Disease_progression |
ISS |
8 |
128,892,784 |
128,893,905 |
RGD:734715 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
ISS |
8 |
128,907,157 |
128,912,272 |
RGD:4892094 |
RGD |
| G |
Cd14 |
CD14 molecule |
|
|
ISS |
18 |
29,374,593 |
29,376,190 |
RGD:4144205 |
RGD |
| G |
Cd86 |
CD86 molecule |
|
|
ISS |
11 |
66,215,233 |
66,238,882 |
RGD:4892339 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
|
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:5131287 |
RGD |
| G |
Crp |
C-reactive protein, pentraxin-related |
|
Severity |
ISS |
13 |
88,702,243 |
88,703,153 |
RGD:5131284 |
RGD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
Disease_progression |
ISS |
14 |
18,677,129 |
18,679,175 |
RGD:5135037 |
RGD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
No_Association |
ISS |
19 |
52,713,150 |
52,721,609 |
RGD:4780358 |
RGD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
Susceptibility |
ISS |
2 |
203,575,444 |
203,580,821 |
RGD:4140932 |
RGD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
Susceptibility |
ISS |
20 |
13,604,355 |
13,621,456 |
RGD:4140932 |
RGD |
| G |
Havcr2 |
hepatitis A virus cellular receptor 2 |
|
|
ISS |
10 |
31,585,703 |
31,610,825 |
RGD:5135524 |
RGD |
| G |
Il13 |
interleukin 13 |
|
|
ISS |
10 |
39,093,512 |
39,096,069 |
RGD:4145649 |
RGD |
| G |
Il15 |
interleukin 15 |
|
|
ISS |
19 |
27,487,268 |
27,498,973 |
RGD:4990461 |
RGD |
| G |
Il18 |
interleukin 18 |
|
|
ISS |
8 |
53,936,584 |
53,943,228 |
RGD:4889836 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
ISS |
3 |
116,913,612 |
116,924,114 |
RGD:4142835 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Severity |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143180 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Severity |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:4143179 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
Susceptibility |
ISS |
3 |
116,964,422 |
116,970,867 |
RGD:5147843 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143180 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
|
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143174 |
RGD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
Severity |
ISS |
3 |
2,607,800 |
2,613,216 |
RGD:4143179 |
RGD |
| G |
Il27ra |
interleukin 27 receptor, alpha |
|
|
ISS |
19 |
25,795,355 |
25,807,317 |
RGD:5128486 |
RGD |
| G |
Il4 |
interleukin 4 |
|
Severity |
ISS |
10 |
39,074,582 |
39,080,134 |
RGD:5128550 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
|
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:5128510 |
RGD |
| G |
Il6 |
interleukin 6 |
|
|
ISS |
4 |
456,799 |
461,376 |
RGD:4143257 |
RGD |
| G |
Il6r |
interleukin 6 receptor |
|
|
ISS |
2 |
182,078,049 |
182,128,135 |
RGD:5128632 |
RGD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
|
ISS |
10 |
39,220,600 |
39,227,602 |
RGD:5128719 |
RGD |
| G |
Jun |
jun proto-oncogene |
|
|
ISS |
5 |
115,358,166 |
115,361,259 |
RGD:4889999 |
RGD |
| G |
Lta |
lymphotoxin alpha (TNF superfamily, member 1) |
|
Susceptibility |
ISS |
20 |
3,657,842 |
3,659,848 |
RGD:4143234 |
RGD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
|
ISS |
1 |
233,978,931 |
233,983,824 |
RGD:4889452 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
Susceptibility |
ISS |
20 |
13,191,986 |
13,192,851 |
RGD:4891004 |
RGD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
|
ISS |
3 |
155,985,473 |
155,993,433 |
RGD:5130746 |
RGD |
| G |
Nat1 |
N-acetyltransferase 1 (arylamine N-acetyltransferase) |
|
Susceptibility |
ISS |
16 |
23,845,894 |
23,876,528 |
RGD:4140932 |
RGD |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
Susceptibility |
ISS |
19 |
19,662,337 |
19,697,341 |
RGD:5131510 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
ISS |
10 |
65,036,884 |
65,072,453 |
RGD:4144122 |
RGD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
Severity |
ISS |
1 |
79,708,646 |
79,712,881 |
RGD:6483832 |
RGD |
| G |
Ptpn22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
|
|
ISS |
2 |
199,083,186 |
199,144,309 |
RGD:6484723 |
RGD |
| G |
RT1-Bb |
RT1 class II, locus Bb |
|
Disease_progression |
ISS |
20 |
4,730,559 |
4,736,201 |
RGD:5147614 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
Susceptibility |
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4144875 |
RGD |
| G |
Sftpa1 |
surfactant protein A1 |
|
Susceptibility |
ISS |
16 |
17,570,887 |
17,574,389 |
RGD:4144874 |
RGD |
| G |
Slc11a1 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
|
|
ISS |
9 |
73,714,692 |
73,725,523 |
RGD:5684974 |
RGD |
| G |
Tap1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
|
|
ISS |
20 |
4,790,363 |
4,800,730 |
RGD:6482248 |
RGD |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
Susceptibility |
ISS |
20 |
4,770,446 |
4,784,488 |
RGD:5147851 |
RGD |
| G |
Tlr1 |
toll-like receptor 1 |
|
|
ISS |
|
|
|
RGD:4889525 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
Susceptibility |
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145323 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145320 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
Susceptibility |
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145304 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
|
ISS |
2 |
175,607,990 |
175,613,992 |
RGD:4145355 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
Severity |
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144106 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
|
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144205 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
Susceptibility |
ISS |
5 |
83,564,100 |
83,577,735 |
RGD:4144122 |
RGD |
| G |
Tlr9 |
toll-like receptor 9 |
|
|
ISS |
|
|
|
RGD:5130704 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
Susceptibility |
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143388 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
Disease_progression |
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4143395 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
ISS |
20 |
3,661,000 |
3,663,618 |
RGD:4142835 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
Susceptibility |
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:4889849 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:4889853 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
|
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:4889845 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
Susceptibility |
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:4889842 |
RGD |
| G |
Vdr |
vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
Susceptibility |
ISS |
7 |
136,567,614 |
136,617,280 |
RGD:4889830 |
RGD |
Tuberculosis, Renal
|
| G |
Il4r |
interleukin 4 receptor |
|
|
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:5128510 |
RGD |
| G |
Il4r |
interleukin 4 receptor |
|
|
ISS |
1 |
184,612,903 |
184,637,863 |
RGD:7207069 |
RGD |
Term paths to the root
| Path 1 |
Diseases |
30477 |
 |
Bacterial Infections and Mycoses |
1471 |
 |
Bacterial Infections |
522 |
 |
Gram-Positive Bacterial Infections |
229 |
 |
Actinomycetales Infections |
162 |
 |
Mycobacterium Infections |
162 |
 |
Tuberculosis |
123 |
 |
Latent Tuberculosis |
0 |
 |
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO |
11 |
 |
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1 |
0 |
 |
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2 |
0 |
 |
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3 |
0 |
 |
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED |
0 |
 |
Peritonitis, Tuberculous |
0 |
 |
Tuberculoma + |
0 |
 |
Tuberculosis, Avian |
0 |
 |
Tuberculosis, Bovine |
0 |
 |
Tuberculosis, Cardiovascular + |
0 |
 |
Tuberculosis, Central Nervous System + |
1 |
 |
Tuberculosis, Cutaneous + |
0 |
 |
Tuberculosis, Endocrine |
0 |
 |
Tuberculosis, Gastrointestinal |
0 |
 |
Tuberculosis, Hepatic |
0 |
 |
Tuberculosis, Laryngeal |
0 |
 |
Tuberculosis, Lymph Node + |
0 |
 |
Tuberculosis, Miliary |
0 |
 |
Tuberculosis, Multidrug-Resistant + |
2 |
 |
Tuberculosis, Ocular |
0 |
 |
Tuberculosis, Oral |
0 |
 |
Tuberculosis, Osteoarticular + |
0 |
 |
Tuberculosis, Pleural + |
8 |
 |
Tuberculosis, Pulmonary + |
70 |
 |
Tuberculosis, Splenic |
0 |
 |
Tuberculosis, Urogenital + |
2 |
 |
| |
|